HPV genotype distribution in older Danish women undergoing surgery due to cervical cancer.

Anne Hammer Else Mejlgaard Patti E Gravitt Estrid V S Høgdall Pernille Christiansen Torben Steiniche Jan Blaakær

Published in: Acta obstetricia et gynecologica Scandinavica (2015)

In the absence of waning immunity, the nonavalent HPV vaccine would be predicted to reduce cervical cancer burden in Denmark across a broader age-range compared with the reduced type-spectrum vaccines.

Keyphrases

cervical cancer screening
high grade
minimally invasive
coronary artery bypass
physical activity
community dwelling
pregnancy outcomes
middle aged
risk factors
coronary artery disease
acute coronary syndrome
atrial fibrillation
breast cancer risk